Applied Therapeutics, Inc. (APLT) earnings
APLT earnings moved a median of +0.78% by the close. Quarterly and annual APLT reports and results, each read against the price at its own news timestamp. Back to the APLT overview →
15 measured APLT earnings events.
Where these APLT earnings landedvs 13 measured APLT earnings reactions
| Middle 50% of APLT earnings reactions | -2.38% to +8.86% |
|---|---|
| Median reaction (to close) | +0.78% |
| Measured reactions | 13 |
Point-in-time · zero look-ahead
Half of the 13 APLT earnings events with a measured close landed between -2.38% and +8.86%; 54% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Applied Therapeutics Reports Third Quarter 2025 Financial Results | Press release | +1.63% | — | |
| Form 10-Q Applied Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +1.63% | — | |
| Applied Therapeutics Reports Second Quarter 2025 Financial Results | Press release | -0.58% | +8.86% | |
| Form 10-Q Applied Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -0.58% | +8.86% | |
| Form 10-Q Applied Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +2.23% | +13.39% | |
| Applied Therapeutics Reports First Quarter 2025 Financial Results | Press release | +2.23% | +13.39% | |
| Form 10-K Applied Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -0.71% | -10.08% | |
| Form NT 10-K Applied Therapeutics, For: Dec 31 | SEC filing · Form NT | -2.16% | -2.38% | |
| Applied Therapeutics Reports Third Quarter 2024 Financial Results | Press release | -0.41% | +0.93% | |
| Form 10-Q Applied Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.41% | +0.93% | |
| Applied Therapeutics Reports Second Quarter 2024 Financial Results | Press release | +0.96% | -1.12% | |
| Form 10-Q Applied Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.96% | -1.12% | |
| Applied Therapeutics Reports First Quarter 2024 Financial Results | Press release | -1.77% | -3.55% | |
| Form 10-Q Applied Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -1.77% | -3.55% | |
| Form 10-K Applied Therapeutics For: Dec 31 | SEC filing · Form 10-K | +1.95% | +0.78% |
Keep exploring
More APLT: analyst actions → · SEC filings → · APLT overview →